Sfoglia per AUTORE
LIU L
Collezione AOU Città della Salute di Torino

  

Items : 5

Reassuring pregnancy outcomes in women with mild COL4A3-5-related disease (Alport syndrome) and genetic type of disease can aid personalized counseling. in Kidney international / Kidney Int. 2024 May;105(5):1088-1099. doi: 10.1016/j.kint.2024.01.034. Epub 2024 Feb 19.
2024
AOU Città della Salute di Torino

Lely AT; Hall M; Liu L; Hladunewich MA; Ralston ER; Wiles K; Torra R; Bramham K; Furlano M; Mastrangelo A; Vogt L; Gillion V; de Jong MFC; Servais A; Tory K; Claes KJ; van Calsteren K; Attini R; Miglinas M; Groen H; Cerkauskiene R; van Bakel SPJ; Vollenberg R; Cerkauskaite-Kerpauskiene A; Snoek R; Gosselink ME; van Eerde AM;

Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease. in Nature communications / Nat Commun. 2023 Nov 30;14(1):7836. doi: 10.1038/s41467-023-43020-9.
2023
AOU Città della Salute di Torino

Gupta Y; Friedman DJ; McNulty MT; Khan A; Lane B; Wang C; Ke J; Jin G; Wooden B; Knob AL; Lim TY; Appel GB; Huggins K; Liu L; Mitrotti A; Stangl MC; Bomback A; Westland R; Bodria M; Marasa M; Shang N; Cohen DJ; Crew RJ; Morello W; Canetta P; Radhakrishnan J; Martino J; Liu Q; Chung WK; et alii...

The genetic architecture of membranous nephropathy and its potential to improve non-invasive diagnosis. in Nature communications / Nat Commun. 2020 Mar 30;11(1):1600. doi: 10.1038/s41467-020-15383-w.
2020
ASL Torino 4
AOU Città della Salute di Torino

Kiemeney LA; Akilesh S; Coenen MJH; Hofstra JM; Köttgen A; Eckardt KU; Wuttke M; Kenny EE; Ashman N; Loos RJF; Stanescu HC; Bockenhauer D; Connolly J; Powis S; Pepper RJ; Dufek S; Issler N; Cheshire C; Gupta S; Harris S; Hamilton P; Pani A; Fervenza FC; Cattran DC; Amoroso A; Kim DK; Suzuki H; Kim YS; Cho B; et alii...

Genomic Mismatch at LIMS1 Locus and Kidney Allograft Rejection. in The New England journal of medicine / N Engl J Med. 2019 May 16;380(20):1918-1928. doi: 10.1056/NEJMoa1803731.
2019
AOU Città della Salute di Torino

Steers NJ; Li Y; Drace Z; D'Addario JA; Fischman C; Liu L; Xu K; Na YJ; Neugut YD; Zhang JY; Sterken R; Balderes O; Bradbury D; Ozturk N; Ozay F; Goswami S; Mehl K; Wold J; Jelloul FZ; Rohanizadegan M; Gillies CE; Vasilescu EM; Vlad G; Ko YA; Mohan S; Radhakrishnan J; Cohen DJ; Ratner LE; Scolari F; et alii...

Phase II study of copanlisib, a PI3K inhibitor, in relapsed or refractory, indolent or aggressive lymphoma. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Sep 1;28(9):2169-2178. doi: 10.1093/annonc/mdx289.
2017
AOU Città della Salute di Torino

Dreyling M; Morschhauser F; Bouabdallah K; Bron D; Cunningham D; Assouline SE; Verhoef G; Linton K; Thieblemont C; Vitolo U; Hiemeyer F; Giurescu M; Garcia-Vargas J; Gorbatchevsky I; Liu L; Koechert K; Peña C; Neves M; Childs BH; Zinzani PL;